TREA

88064917 - STEMCYTE

Follow

Information

  • Trademark
  • 88064917
  • Serial Number
    88064917
  • Registration Number
    5882064
  • Filing Date
    August 03, 2018
    7 years ago
  • Registration Date
    October 15, 2019
    6 years ago
  • Transaction Date
    February 22, 2025
    11 months ago
  • Status Date
    February 22, 2025
    11 months ago
  • Published for Opposition Date
    July 30, 2019
    6 years ago
  • Location Date
    February 22, 2025
    11 months ago
  • First Use Anywhere Date
    January 01, 2017
    9 years ago
  • First Use In Commerce Date
    January 01, 2017
    9 years ago
  • Status Code
    702
  • Current Location
    Historical data usage
    Employee Name
    OPUTA, CHIOMA
  • Attorney Docket Number
    48609000012
    Attorney Name
    John K. Burke
  • Owners
Information
Mark Drawing Code
3
Mark Identification
STEMCYTE
Case File Statements
  • GS0401: Biomedical services, namely, umbilical cord blood processing for transplant
  • DM0000: The mark consists of the stylized word "STEMCYTE" above a horizontal line and to the right of a baby and heart design.
  • GS0391: Biomedical services, namely, storage of human tissue, blood, blood components and stem cells
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Biomedical services, namely, the collection, medical screening, medical testing, and medical typing of human tissue, blood, blood components and stem cells for diagnostic or treatment purposes; providing medical consulting services in the field of biomedicine, pathology and laboratory medicine; providing medical advice in the field of medical care; diagnosis of disease based on professional interpretation of pathology and laboratory medicine results
  • GS0421: Biomedical services, namely, analysis of human tissue, blood, blood components and stem cells for scientific research purposes; medical reference laboratory services and clinical laboratory services for others featuring the testing, screening and analysis of biological substances, human leukocyte antigen DNA and serological typing and blood typing; scientific research consulting in the field of biomedicine, pathology, and laboratory medicine; providing scientific research advice in relation to medical science
Case File Event Statements
  • 8/7/2018 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/22/2019 - 6 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/9/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/10/2018 - 7 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 11/21/2018 - 7 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/18/2018 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/18/2018 - 7 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/18/2018 - 7 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/18/2019 - 6 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/22/2019 - 6 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 6/22/2019 - 6 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/30/2019 - 6 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/25/2019 - 6 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/26/2019 - 6 years ago
    13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/10/2019 - 6 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/30/2019 - 6 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/15/2024 - a year ago
    18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/15/2019 - 6 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/16/2024 - a year ago
    19 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 2/21/2025 - 11 months ago
    20 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/22/2025 - 11 months ago
    21 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 2/22/2025 - 11 months ago
    22 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85